Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
last updated: 12 Jun 2014
Uso de la vacuna aviar recombinante para inmunización activa contra la enfermedad de Marek (MD) y la enfermedad de Gumboro (1BD)
ES
-
Competent National Authority:Instituto Colombiano Agropecuario ICA ()Avenida Carrera 20 # 83-20, edificio NeoPoint 83Bogotá, Bogotá D.C.
110221, ColombiaPhone: (+57)-601-794-4492,Fax:Website: http://www.ica.gov.co,
-
Person:Sr MARTIN EMILIO RODRIGUEZ MOSQUERAPROFESIONAL ESPECIALIZADO,CRA 41 #17-81 ZONA INDUSTRIAL PUENTE ARANDA.BOGOTA, CUNDINAMARCA
, ColombiaPhone: 0571-3323700 EXT 1366 1361,Fax: 0571-3323700,Email: martin.rodriguez@ica.gov.co,Website:Related OrganizationINSTITUTO COLOMBIANO AGROPECUARIO ICA (ICA)Government agency (National/Federal)CRA 41 #17-81 ZONA INDUSTRIAL PUENTE ARANDA.BOGOTA, CUNDINAMARCA
, ColombiaPhone: 0571-3323700 EXT 1366 1361,Fax: 0571-3323700,Email: martin.rodriguez@ica.gov.co,Website:
-
VECTORMUNE® HVT-IBD| Ceva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
- Res 2399 de 2010 vacuna aviar.pdf [ Spanish ]
EN
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | Risk assessment | 1 | |
